Self-Report versus Clinician Examination in Early Parkinson's Disease.

ABSTRACT:

Background

Evaluating the discrepancies between patient-reported measures and clinician examination has implications for formulating individual treatment regimens.

Objective

This study investigated the association between health outcomes and level of self-reported motor-related function impairment relative to clinician-examined motor signs.

Methods

Recently diagnosed PD patients were evaluated using the Parkinson's Progression Marker Initiative (PPMI, N = 420) and the PASADENA phase II clinical trial (N = 316). We calculated the average normalized difference between each participant's part II and III MDS-UPDRS (Movement Disorder Society Unified Parkinson's Disease Rating Scale) scores. Individuals with score differences <25th or >75th percentiles were labeled as low-

SUBMITTER: Zolfaghari S 

PROVIDER: S-EPMC9299700 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature